Patients were treated for 80 days with ALA (600 mg/day, treatment group) or with a placebo (control group)
Nauck MA, Heimesaat MM, Behle K, Holst JJ, Nauck MS, Ritzel R, Hfner M, Schmiegel WH: Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers
These are designed to control blood sugar and also help regulate weight by reducing hunger pangs and food intake
A pivotal safety analysis of the STEP trials found that the overall safety profile is well-characterized and serious adverse events are rare (Wilding et al., New England Journal of Medicine , 2021)
That said, here are a few steps to help you locate them: 1
None replicates the broad endocrine effects of testosterone